Rentabilidad en 3 años
Fondo | Fecha | |||||
---|---|---|---|---|---|---|
3 años | ||||||
![]() ![]() | ||||||
FRANKLIN GENOMIC ADVANCEMENTS I (ACC) USD | 18/06 | -18,19% | ||||
GOLDMAN SACHS ALL CHINA EQUITY PORTFOLIO R GBP DIS | 18/06 | -18,19% | ||||
JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | 18/06 | -18,19% | ||||
AXA WORLD FUNDS-GLOBAL INFLATION BONDS A DIS EUR | 18/06 | -18,20% | ||||
GOLDMAN SACHS ALL CHINA EQUITY PORTFOLIO BASE USD CAP | 18/06 | -18,20% | ||||
SCHRODER ISF CHINA OPPORTUNITIES K1 ACC USD | 18/06 | -18,21% | ||||
PRIVILEDGE - ALLIANZ ALL CHINA EQUITY (EUR) P CAP SYST. HDG | 17/06 | -18,22% | ||||
BGF CHINA BOND D3 USD | 18/06 | -18,24% | ||||
BGF WORLD HEALTHSCIENCE A2 JPY (HEDGED) | 18/06 | -18,24% | ||||
JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | 18/06 | -18,24% |